Quantum-Si (NASDAQ:QSI - Get Free Report) is expected to post its Q1 2025 quarterly earnings results after the market closes on Thursday, May 15th. Analysts expect Quantum-Si to post earnings of ($0.17) per share and revenue of $0.96 million for the quarter.
Quantum-Si Price Performance
NASDAQ QSI traded down $0.07 during trading hours on Friday, reaching $1.26. The company's stock had a trading volume of 3,619,450 shares, compared to its average volume of 9,848,361. The firm has a market capitalization of $230.76 million, a price-to-earnings ratio of -1.97 and a beta of 2.71. The company's 50-day moving average is $1.25 and its two-hundred day moving average is $1.56. Quantum-Si has a 1-year low of $0.61 and a 1-year high of $5.77.
Analyst Ratings Changes
QSI has been the subject of several research analyst reports. National Bankshares set a $3.65 target price on Quantum-Si in a research note on Wednesday, March 5th. Alliance Global Partners reaffirmed a "buy" rating on shares of Quantum-Si in a report on Wednesday, March 5th. Finally, HC Wainwright reissued a "buy" rating and set a $5.50 target price on shares of Quantum-Si in a research note on Tuesday, January 14th.
Read Our Latest Analysis on QSI
Insider Buying and Selling
In related news, CEO Jeffrey Alan Hawkins sold 23,707 shares of the company's stock in a transaction dated Friday, March 21st. The shares were sold at an average price of $1.39, for a total transaction of $32,952.73. Following the completion of the sale, the chief executive officer now owns 2,646,716 shares of the company's stock, valued at approximately $3,678,935.24. This represents a 0.89 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last ninety days, insiders sold 36,650 shares of company stock worth $50,944. 30.04% of the stock is owned by corporate insiders.
About Quantum-Si
(
Get Free Report)
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Read More
Before you consider Quantum-Si, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.
While Quantum-Si currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
